Symposia: Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Antibody Therapy, Acute Myeloid Malignancies, Combination therapy, AML, MDS, Clinical trials, Adult, Bispecific Antibody Therapy, Drug development, Chemotherapy, Clinical Research, Chronic Myeloid Malignancies, Diseases, Gene Therapy, Treatment Considerations, Biological therapies, Immunology, Immunotherapy, Adverse Events, Non-Biological therapies, Biological Processes, Myeloid Malignancies, Technology and Procedures, Gene editing, Study Population, Human, Measurable Residual Disease , Vaccines
Type: Poster
Hematology Disease Topics & Pathways:
Research, Antibody Therapy, Acute Myeloid Malignancies, Combination therapy, AML, MDS, Clinical trials, Adult, Bispecific Antibody Therapy, Drug development, Chemotherapy, Clinical Research, Chronic Myeloid Malignancies, Diseases, Gene Therapy, Treatment Considerations, Biological therapies, Immunology, Immunotherapy, Adverse Events, Non-Biological therapies, Biological Processes, Myeloid Malignancies, Technology and Procedures, Gene editing, Study Population, Human, Measurable Residual Disease , Vaccines
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH